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ABSTRACT 
 
Any disorder that reduces the digestion or absorption of food, or alters its passage 
through the digestive tract, can be called a digestive disorder. Gastrointestinal (GI) disorders 
affect a cat's stomach and intestines, resulting in pain and other problems. Efficient digestion is 
essential for your cat to be able to build and repair tissues and obtain energy. Digestive disorders 
in cats are quite common and most clear up within a few days. But some cats need long-term 
management because they have regular or permanent digestive problems. GI disorders can lead, 
to dehydration, acid-base and electrolyte imbalances and malnutrition so it is important to 
recognize the signs Cats with intestinal disease have a wide range of clinical signs. Weight loss, 
despite a normal or increased appetite is very common. Cats that are chronically ill usually have 
a loss of fat over the spine (so that the spine is palpable). Other cats have routinely vomit food, 
fluid and or hairball. Contrary to what many pet lovers believe, hairballs are not normal in cats, 
and they are not due to a "grease deficiency". The clinical signs of cats with intestinal disease are 
often similar to those of other diseases (chronic kidney disease, urinary tract obstruction in male 
cats, chronic progressive kidney disease, diabetes and hyperthyroidism). Gastro intestinal 
problem in cat is a significant health problem for which there is no universally accepted 
pharmacological treatment. The combination of Viusid pet is supplementary Food. It is a food 
preparation consisting of antioxidants, vitamins, trace mineral, and a component extracted from 
liquorice root (glycyrrhizinic acid). It is specially designed to supplement immune defenses. 
Targeted nutrition for those processes that cause immunodeficiency. Given viusid for 5 days to 
cat abaout 1 cc once a day effected for Gastrointestinal problem specialy virus problem like 
panleukopenia or hepatitis. Using viusid as immonodilator non kortikosteroid for cat need more 
clinical trial to make sure that effected.  
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INTRODUCTION 
 
Any disorder that reduces the digestion or absorption of food, or alters its passage 
through the digestive tract, can be called a digestive disorder. Gastrointestinal (GI) disorders 
affect a cat's stomach and intestines, resulting in pain and other problems. Efficient digestion is 
essential for your cat to be able to build and repair tissues and obtain energy. Digestive disorders 
in cats are quite common and most clear up within a few days. But some cats need long-term 
management because they have regular or permanent digestive problems. GI disorders can lead, 
to dehydration, acid-base and electrolyte imbalances and malnutrition so it is important to 
recognize the signs Cats with intestinal disease have a wide range of clinical signs. Weight loss, 
despite a normal or increased appetite is very common. Cats that are chronically ill usually have 
a loss of fat over the spine (so that the spine is palpable). Other cats have routinely vomit food, 
fluid and or hairball.  So many pet lovers believe, hairballs are not normal in cats, and they are 
not due to a "grease deficiency". As a result,  we do not recommend the use of over-the-counter 
"hairball remedies" or "hairball diets."Other cats with gastrointestinal disease have diarrhea or 
constipation. Still others have reductions in their normal appetite, or do not eat for one or more 
days. Because the clinical signs of cats with intestinal disease are often similar to those of other 
diseases (chronic kidney disease, urinary tract obstruction in male cats, chronic progressive 
kidney disease, diabetes and hyperthyroidism). 
With the increasing prevalence of obesity, for many cat diabetes and the metabolic 
syndrome in the general population, nonalcoholic fatty liver disease (NAFLD) has become the 
main cause of chronic liver disease worldwide.The histological features of NAFLD range from 
fat alone (simple steatosis) to fat plus inflammation with or without fibrosis (steatohepatitis). 
Nonalcoholic steatohepatitis (NASH) is a more severe subtype of NAFLD, which may progress 
to cirrhosis and hepatocellular carcinoma.Thus, treatment of NASH is to halt the progression of 
the disease. Pharmacological agents such as insulin sensitizers, antioxidant agents, or lipid-
lowering agents20, 21 have been tested in clinical trials; however, there is no conclusive 
evidence to support their use in clinical practice. Thiazolidinediones (TZDs) have shown 
promise in the treatment of NASH; however, their favourable effects on liver histology and liver 
biochemistries disappear on their discontinuation, suggesting that long-term treatment is needed 
to maintain therapeutic benefits.15 This is a potentially significant issue; recent studies have 
questioned the long-term safety of TZDs (especially rosiglitazone). A recent study raised the 
possibility that TZDs alone without lifestyle modification may not be as effective. In the 
pathogenesis of NAFLD, lipid peroxidation and overabundance of reactive oxygen species are 
key mediators in the progression from relatively stable hepatic steatosis to potentially 
progressive steatohepatitis. This provides a rationale for studies using antioxidant agents; 
however, trials involving these agents have not clearly demonstrated their potential benefits on 
histological (steatosis, inflammation and fibrosis) and metabolic (insulin resistance) endpoints, in 
part limited by small sample size, lack of dependable endpoints and poor control on lifestyle 
modification such as diet,weight loss and exercise. Evidence of the efficacy of diet and exercise 
in patients with NAFLD is surprisingly scant. However, as this kind of lifestyle modification is 
comparatively safe, inexpensive and has other health benefits, it could be proposed as first-line 
treatment for obese patients with NAFLD, despite the limited evidence to support its efficacy. 
There is an obvious need for the continuous development of new treatment strategies for NASH. 
Thus, the addition of an antioxidant agent to weight loss through diet and exercise could increase 
the beneficial effects on histology, particularly in patients with poor diet compliance.  
 
DISCUSSION 
 
A client ward in Animal Hospital with anamnesa and medical record  as represented in the table. 
 
Medical Record 
 
Name  : Cat Kino 
Sex  : Male 
Age  : 4 year 
Weight : 4.9 kg 
Diagnosa : Gastrointestinal 
Veterinarian : Drh. Miyayu 
 
Day and date  Time  T  P  R  Ttreatment  Feeding  Note 
Monday 
Sept 12th 2017  
08.00  39,3  78  90  Viusid 1 ml    Fluid terapi
(iv)   
  21.30  39,1  126  42       No urine,  
diarrhea, 
anorexia 
Tuesday 
Sept 13th  2017 
08.00  39,2  110  42  Viusid 1 ml     
  11.00  38,7  126  36       
 
  14.00  38,7  120  36       
Wednesday 
Sept 14th 2017 
06.00        Dexa 0,5 ml 
Viusid 1 ml 
  Urinasi dan 
Defekasi 
(N) 
18.00  38,4  120  30  Dexa 0,5 ml  Whiskas   
 
 
 
21.00          Whiskas   
Thursday 
Sept 15th 2017 
07.00  39,1  120  36  Dexa 0,5 ml 
Viusid 1 ml 
Whiskas  Urinasi dan 
Defekasi 
(N) 
  10.00  38,6  126  48       
  13.00  38,0  138  48   Dexa 0,5 cc 
Viusid 1 ml 
   
  16.00  38,3  120  36    Whiskas  Defekasi 
(N) 
Friday 
Sept 16th 2017 
08.00          Whiskas 
and drink 
Urinasi (N) 
  10.00  38,1  126  48   Dexa 0,5 ml     
  15.00  38,1  120  54   Dexa 0,5 ml     
 
 
Gastro intestinal problem in cat is a significant health problem for which there is no universally 
accepted pharmacological treatment. The combination of Viusid® pet is supplementary Food. It is a food 
preparation consisting of antioxidants, vitamins, trace mineral, and a component extracted from liquorice 
root (glycyrrhizinic acid). It is specially designed to supplement immune defenses. Targeted nutrition for 
those processes that cause immunodeficiency. The benefit may be augmented by Viusid®or perhaps other 
antioxidants in an attempt to prevent disease progression. Additional studies are required to confirm the 
long-term effect of Viusid® in these patients as well as in patients with inadequate compliance with 
lifestyle modification. Figure 1. have interpretation that cat with increasing radiopasitas on level ren and 
blader and more spesifik have gas in intestinal. As similar problem on Gastrointestinal and urinary tract 
disease.  
 
 
 
 
 
 
 
 
 
Figure 1. Foto x ray  “Kino” with  Lateral Abdomen position 
Mobile x ray use mA 2,5 kvp 1.25 with radiopague in level ren and some gas in intestinal  
 
 
 
 
CONCLUSION 
Given viusid for 5 days to cat abaout 1 ml once a day effected for Gastrointestinal problem 
specialy virus problem like panleukopenia or hepatitis. Using viusid® as immonodilator non 
kortikosteroid for cat need more clinical trial to make sure that effected 
Ingredients of Viusid 
Malic acid                   0.666g                        Cyanocobalamine                0.3 µg 
Ascorbic acid              0.020g                       Arginin                                  0.666g 
Glycyrrhizic acid        0.033g                       Zinc Sulphate                        0.005g 
Folic acid                    66 µg                         Glycine                                  0.333g 
Glucosamine               0.666g                       Pyrodoxal                              0.6mg 
                                                                      Calcium panthothenate          0.002g 
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